For all other patients, testing should begin at age 35 years.ĥ. Women who were diagnosed with GDM should have lifelong testing at least every 3 years.Ĥ. Patients with prediabetes (A1C ≥5.7%, impaired glucose tolerance, or impaired fasting glucose]) should be tested yearly.ģ. Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans)Ģ.HDL cholesterol level 250 mg/dL (2.82 mmol/L).Hypertension (≥140/90 mmHg or on therapy for hypertension).
High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander).Testing should be considered in adults with overweight or obesity (BMI ≥25 kg/m 2 or ≥23 kg/m 2 in Asian Americans) who have one or more of the following risk factors:
